Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL. |  |
|
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| McCulloch Kevin | See Remarks | Jan 08 '26 | Sale | 8.00 | 15,000 | 120,000 | 1,685,426 | Jan 09 05:34 PM | | KEVIN MCCULLOCH | Officer | Jan 08 '26 | Proposed Sale | 7.21 | 60,000 | 432,600 | | Jan 08 04:22 PM | | Shannon John Patrick Jr | See Remarks | Jan 05 '26 | Option Exercise | 1.63 | 92,301 | 149,998 | 2,797,647 | Jan 06 06:14 PM | | Shannon John Patrick Jr | See Remarks | Jan 05 '26 | Sale | 7.08 | 24,907 | 176,257 | 2,705,346 | Jan 06 06:14 PM | | Hecht Beth | See Remarks | Jan 02 '26 | Sale | 7.43 | 16,667 | 123,776 | 1,308,103 | Jan 05 06:01 PM | | JOHN H JOHNSON | Director | Dec 19 '25 | Proposed Sale | 7.22 | 135,402 | 977,034 | | Dec 19 06:15 PM | | JOHNSON JOHN | Director | Dec 19 '25 | Sale | 7.22 | 135,400 | 977,019 | 698,083 | Dec 19 05:17 PM | | BORMANN-KENNEDY BARBARA-JEAN A | Director | Dec 12 '25 | Sale | 7.09 | 15,000 | 106,414 | 142,500 | Dec 15 05:24 PM | | BARBARA-JEAN A BORMANN-KENNEDY | Director | Dec 12 '25 | Proposed Sale | 7.01 | 15,000 | 105,150 | | Dec 12 04:20 PM | | Hecht Beth | See Remarks | Dec 01 '25 | Sale | 7.01 | 16,667 | 116,781 | 1,320,176 | Dec 02 05:14 PM | | Shannon John Patrick Jr | See Remarks | Nov 14 '25 | Option Exercise | 1.55 | 87,100 | 135,005 | 2,730,253 | Nov 17 05:58 PM | | Shannon John Patrick Jr | See Remarks | Nov 13 '25 | Option Exercise | 1.55 | 8,970 | 13,904 | 2,666,395 | Nov 17 05:58 PM | | Shannon John Patrick Jr | See Remarks | Nov 13 '25 | Sale | 7.46 | 23,242 | 173,402 | 2,643,153 | Nov 17 05:58 PM | | Hecht Beth | See Remarks | Nov 11 '25 | Sale | 7.40 | 16,667 | 123,296 | 1,336,843 | Nov 13 06:59 PM | | JOHN SHANNON | Director | Nov 13 '25 | Proposed Sale | 7.59 | 48,149 | 365,451 | | Nov 13 04:25 PM | | BETH HECHT | Officer | Nov 11 '25 | Proposed Sale | 7.72 | 66,668 | 514,677 | | Nov 12 07:02 AM | | PERSKY MARLA | Director | Sep 11 '25 | Sale | 7.72 | 15,500 | 119,610 | 142,000 | Sep 12 05:09 PM | | MARLA PERSKY | Director | Sep 11 '25 | Proposed Sale | 7.81 | 15,500 | 121,055 | | Sep 11 04:24 PM | | SHERMAN JEFFREY W | Director | Aug 28 '25 | Option Exercise | 6.66 | 47,040 | 313,286 | 261,420 | Aug 29 05:21 PM | | SHERMAN JEFFREY W | Director | Aug 28 '25 | Sale | 7.92 | 42,232 | 334,515 | 219,188 | Aug 29 05:21 PM | | JEFFREY SHERMAN | Director | Aug 28 '25 | Proposed Sale | 7.92 | 42,232 | 334,511 | | Aug 28 04:09 PM | | JOHNSON JOHN | Director | Aug 13 '25 | Sale | 7.32 | 107,500 | 786,459 | 833,483 | Aug 15 04:57 PM | | HALKUFF DAWN | Director | Aug 12 '25 | Sale | 7.28 | 42,500 | 309,226 | 115,000 | Aug 13 04:47 PM | | JOHN H JOHNSON | Director | Aug 13 '25 | Proposed Sale | 7.32 | 107,500 | 786,452 | | Aug 13 04:08 PM | | DAWN HALKUFF | Director | Aug 12 '25 | Proposed Sale | 7.28 | 42,500 | 309,226 | | Aug 12 04:23 PM | | McCulloch Kevin | See Remarks | Jun 13 '25 | Buy | 4.38 | 25,000 | 109,475 | 1,708,585 | Jun 16 04:26 PM | | Fairley Ricki Louise | Director | May 09 '25 | Proposed Sale | 4.90 | 56,667 | 277,668 | | May 09 05:28 PM | | Hecht Beth | See Remarks | Mar 20 '25 | Sale | 5.43 | 40,000 | 217,244 | 1,353,510 | Mar 21 05:31 PM | | Hecht Beth | Officer | Mar 20 '25 | Proposed Sale | 5.14 | 40,000 | 205,600 | | Mar 20 05:26 PM |
|
